Susquehanna International Group’s SELLAS Life Sciences SLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$32.2M Buy
7,624,100
+1,928,600
+34% +$8.63M 0.04% 1665
2025
Q4
$21.5M Buy
5,695,500
+2,907,400
+104% +$5.65M 0.03% 2128
2025
Q3
$4.49M Buy
2,788,100
+2,557,300
+1,108% +$4.56M 0.01% 4256
2025
Q2
$505K Buy
230,800
+219,400
+1,925% +$337K ﹤0.01% 9157
2025
Q1
$12.3K Sell
11,400
-1,523,400
-99% -$1.81M ﹤0.01% 12198
2024
Q4
$1.6M Buy
1,534,800
+78,600
+5% +$89.7K ﹤0.01% 5805
2024
Q3
$1.82M Sell
1,456,200
-183,700
-11% -$225K ﹤0.01% 5449
2024
Q2
$1.95M Buy
1,639,900
+267,200
+19% +$364K ﹤0.01% 5146
2024
Q1
$1.39M Buy
1,372,700
+865,100
+170% +$727K ﹤0.01% 6181
2023
Q4
$538K Buy
507,600
+459,700
+960% +$497K ﹤0.01% 8482
2023
Q3
$78.6K Buy
47,900
+4,000
+9% +$6.31K ﹤0.01% 11077
2023
Q2
$68.9K Sell
43,900
-112,000
-72% -$180K ﹤0.01% 11191
2023
Q1
$223K Sell
155,900
-129,200
-45% -$320K ﹤0.01% 10362
2022
Q4
$673K Buy
285,100
+129,300
+83% +$363K ﹤0.01% 7121
2022
Q3
$315K Buy
155,800
+26,700
+21% +$73.7K ﹤0.01% 9680
2022
Q2
$288K Buy
129,100
+83,300
+182% +$244K ﹤0.01% 9675
2022
Q1
$306K Sell
45,800
-25,900
-36% -$151K ﹤0.01% 10237
2021
Q4
$397K Sell
71,700
-100,800
-58% -$763K ﹤0.01% 9802
2021
Q3
$1.58M Buy
172,500
+115,800
+204% +$1.07M ﹤0.01% 6348
2021
Q2
$629K Sell
56,700
-108,900
-66% -$1.06M ﹤0.01% 9009
2021
Q1
$1.41M Buy
165,600
+136,100
+461% +$1.11M ﹤0.01% 6809
2020
Q4
$171K Buy
+29,500
New +$118K ﹤0.01% 10162
2019
Q1
Sell
-280
Closed -$17K 10337
2018
Q4
$17K Hold
280
﹤0.01% 8699
2018
Q3
$17K Hold
280
﹤0.01% 9013
2018
Q2
$48K Hold
280
﹤0.01% 9284
2018
Q1
$48K Buy
280
+167
+148% +$47.7K ﹤0.01% 8962
2017
Q4
$44K Sell
113
-9
-7% -$4.35K ﹤0.01% 8940
2017
Q3
$64K Sell
122
-6
-5% -$3.96K ﹤0.01% 8488
2017
Q2
$112K Buy
128
+4
+3% +$3.48K ﹤0.01% 8637
2017
Q1
$113K Sell
124
-563
-82% -$932K ﹤0.01% 8336
2016
Q4
$2M Buy
+687
New +$3.99M 0.01% 4070

Other funds holding SLS